A Saudi Heart Association Position Statement on Obesity and Cardiovascular Disease
The expert panel explored studies on obesity and its implication on CVD assessment modalities, while also examining the efficacy and cardiovascular safety of available interventions for weight reduction. The association between obesity and CVD is undeniable. The treatment of obesity, be it through lifestyle changes, pharmacological therapy or surgery, is an effective strategy for both weight loss as well as the primary and secondary prevention of CVD. The Saudi Heart Association position statement thus provides guidance and recommendations for the management of obesity/overweight and CVD in Saudi Arabia. This position statement is expected to contribute towards obesity and CVD prevention efforts in Saudi Arabia by promoting adequate and time-appropriate treatment of these conditions.
Authors
- Waleed AlHabeeb (ORCID: https://orcid.org/0000-0003-2985-482X)
- Ali Almasood (ORCID: https://orcid.org/0000-0002-7854-7984)
- Suleiman Kharabsheh
- Saud Alsifri
- Abeer Bakhsh (ORCID: https://orcid.org/0000-0002-3512-2476)
- Adel Tash (ORCID: https://orcid.org/0000-0001-7067-6303)
- Abdulhalim Jamal Kinsara (ORCID: https://orcid.org/0000-0002-6414-8720)
- Kamal Alghalayini (ORCID: https://orcid.org/0000-0002-1093-5876)
- Afaf Alshammary
- Mohammed Arafah (ORCID: https://orcid.org/0000-0002-6664-4584)
- Osama Hamdy (ORCID: https://orcid.org/0000-0002-1919-0268)
- Wail Alkattan
Institutions
- Joslin Diabetes Center (US)
- Harvard University (US)
- Prince Sultan University (SA)
- King Abdulaziz University (SA)
- King Saud bin Abdulaziz University for Health Sciences (SA)
- King Faisal Specialist Hospital & Research Centre (SA)
- King Saud University (SA)
- King Abdullah International Medical Research Center (SA)
- Saudi Heart Association (SA)
- King Abdulaziz Hospital (SA)
- Saudi Health Council
- National Guard Health Affairs (SA)
Publication Details
- Journal
- Journal of the Saudi Heart Association
- Published
- 2024-10-17
- DOI
- https://doi.org/10.37616/2212-5043.1391
- Citations
- 2
- Primary Topic
- Cardiovascular Health and Risk Factors
- Type
- article
- Field-Weighted Citation Impact
- 0.80
Funders
- Novo Nordisk